Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Teva
AstraZeneca
Citi
Harvard Business School
Cerilliant
Moodys
UBS
Boehringer Ingelheim

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,105,618

« Back to Dashboard

Which drugs does patent 8,105,618 protect, and when does it expire?

Patent 8,105,618 protects EPIDUO and is included in one NDA.

This patent has thirty patent family members in twenty-two countries.
Summary for Patent: 8,105,618
Title:Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide
Abstract: Dermatological/cosmetic gel compositions suited for preventing or treating cell differentiation and/or proliferation and/or keratinization disorders, including preventing or treating common acne, comprise (i) at least one retinoid, (ii) dispersed benzoyl peroxide and (iii) at least one pH-independent gelling agent, formulated into (iv) a physiologically acceptable medium therefor.
Inventor(s): Orsoni-Segona; Sandrine (Mandelieu, FR), Willcox; Nathalie (Le Rouret, FR)
Assignee: Galderma Research & Development (FR)
Application Number:12/884,684
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 8,105,618

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Galderma Labs Lp EPIDUO adapalene; benzoyl peroxide GEL;TOPICAL 022320-001 Dec 8, 2008 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial TREATMENT OF ACNE ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,105,618

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France01 16747Dec 21, 2001

Non-Orange Book US Patents Family Members for Patent 8,105,618

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,241,649 Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide ➤ Try a Free Trial
8,936,800 Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt ➤ Try a Free Trial
9,814,690 Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt ➤ Try a Free Trial
7,820,186 Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,105,618

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Slovenia 1458369 ➤ Try a Free Trial
Russian Federation 2320327 ➤ Try a Free Trial
Russian Federation 2004122429 ➤ Try a Free Trial
Portugal 1458369 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Chinese Patent Office
Medtronic
Express Scripts
AstraZeneca
McKesson
Covington
Chubb
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.